Covered recipient · General Payments record
RADHIKA RACHAMALLA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2021–2024
$469.01
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $243.37 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $86.49 | 3 |
| Tempus AI, Inc | $32.22 | 1 |
| Daiichi Sankyo Inc. | $28.43 | 1 |
| Merck Sharp & Dohme Corporation | $26.95 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.87 | 1 |
| Acerta Pharma LLC | $17.59 | 1 |
| Adaptive Biotechnologies Corporation | $17.30 | 1 |
| ARRAY BIOPHARMA INC | $14.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.71 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105344482 | CMS |
| ABBVIE INC. | $24.44 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105344487 | CMS |
| ABBVIE INC. | $33.34 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105344491 | CMS |
| Adaptive Biotechnologies Corporation | $17.30 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150262932 | CMS |
| ARRAY BIOPHARMA INC | $14.52 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131364821 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.59 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105833051 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.87 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086213621 | CMS |
| Daiichi Sankyo Inc. | $28.43 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089471715 | CMS |
| Merck Sharp & Dohme LLC | $26.95 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141910918 | CMS |
| Tempus AI, Inc | $32.22 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150172337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.